Klotz U, Reimann I W
Eur J Clin Pharmacol. 1984;26(2):223-6. doi: 10.1007/BF00630289.
In 6 normotensive, healthy male volunteers the pharmacodynamic responses (blood pressure, heart rate; sedation index, tracking test, reaction time) to metoprolol (100 mg bid orally), diazepam (0.1 mg/kg intravenously) and to their combination were studied. The pharmacokinetics of diazepam were also compared in a cross-over experiment, with and without pretreatment by the beta-adrenoceptor antagonist to evaluate the possibility of a drug interaction. The pharmacodynamic and pharmacokinetic investigations indicated that metoprolol only slightly impaired the elimination of diazepam (18% decrease in total clearance, 25% increase in elimination half-life). The pharmacodynamics of metoprolol (17% decrease in heart rate, 17% decrease in diastolic RR) was not significantly altered by the bolus injection of diazepam. The extent of prolongation in choice reaction time (RT2) induced by diazepam was significantly (p = 0.001) more pronounced following the co-administration of metoprolol. However, the results of RT1, the tracking test and the sedation index did not indicate any increased effect due to the beta-blocking agent. It is concluded that concomitant treatment with metoprolol and diazepam causes only minor and clinically irrelevant changes in drug metabolism and drug response.
在6名血压正常的健康男性志愿者中,研究了美托洛尔(口服100 mg,每日两次)、地西泮(静脉注射0.1 mg/kg)及其联合用药的药效学反应(血压、心率、镇静指数、跟踪试验、反应时间)。在一项交叉实验中,还比较了地西泮在有或没有β-肾上腺素能受体拮抗剂预处理情况下的药代动力学,以评估药物相互作用的可能性。药效学和药代动力学研究表明,美托洛尔仅轻微损害地西泮的消除(总清除率降低18%,消除半衰期增加25%)。静脉注射地西泮对美托洛尔的药效学(心率降低17%,舒张压RR降低17%)没有显著影响。美托洛尔与地西泮合用时,地西泮引起的选择反应时间(RT2)延长程度显著更明显(p = 0.001)。然而,RT1、跟踪试验和镇静指数的结果并未显示β受体阻滞剂有任何增强作用。结论是,美托洛尔与地西泮联合治疗仅引起药物代谢和药物反应的轻微且临床无关的变化。